Modified Power Piston Versus Simultaneous Stapedotomy With Hearing Aids in Otosclerosis: A Follow-Up Study Exploring Speech Recognition, Quality of Life and Usage of Device
- PMID: 35170556
- PMCID: PMC8915993
- DOI: 10.1097/MAO.0000000000003514
Modified Power Piston Versus Simultaneous Stapedotomy With Hearing Aids in Otosclerosis: A Follow-Up Study Exploring Speech Recognition, Quality of Life and Usage of Device
Abstract
Objective: To compare audiologic outcomes, quality-of-life (QoL) and usage-of-device (UoD) between case-matched, otosclerotic patients with mixed hearing loss (MHL) which received (a) stapedotomy and postoperative amplification with hearing aids (SDT+HA) or (b) short-incudial process coupled active middle ear implant with simultaneous stapedotomy (mPP).
Study design, setting, and patients: Prospective, matched case-control, follow-up study conducted at two tertiary otologic referral centers. Eligible were all otosclerotic patients with MHL, which received mPP at either of the two institutions. A case-matched-cohort of SDT+HA-patients was generated from the hospitals database based on preoperative audiologic findings.
Main outcome measures: For sound- and speech perception, primary outcome parameters were the mean postoperative, aided air-conduction pure tone average (mpa-AC-PTA) and word recognition score at 80 dB speech level (mpa-WRS), for QoL the mean Nijmegen-Cochlear-Implant-Questionnaire (NCIQ) total-score, and for UoD the mean score rated on a 10-point Likert-scale.
Results: A total of 28 patients were included; 14 received mPP; mpa-AC-PTA and mpa-WRS significantly improved from 47.1 dB-HL to 34.3 dB-HL (-12.8 dB-HL; p < 0.001) and from 75.0% to 93.2% (+18.2%; p = 0.002) compared to 46.5 dB-HL to 31.9 dB-HL (-14.8 dB-HL; p < 0.008) and 75.0% to 93.2% (+18.2%; p = 0.002) for SDT+HA. No significant difference between groups was observed (all p > 0.1). NCIQ total-score between groups did not significantly differ (70.4 vs. 69.9; p = 0.93). UoD for mPP was significantly higher (6.1 vs. 3.0; p < 0.001).
Conclusions: If medical/technical problems prevent usage of HA in otosclerosis with MHL, mPP can be considered as effective treatment option with similar audiological outcome and QoL. A significantly higher UoD for mPP was observed.
Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of Otology & Neurotology, Inc.
Conflict of interest statement
Joachim Schmutzhard is currently receiving a research grant from MedEl (Innsbruck, Austria). None of the other authors named in the submitted work have any conflict of interest including financial, consultant, institutional and or personal relationships that inappropriately bias his or her actions within 3 years of the work beginning. The open access charges have been covered by MED-EL Medical Electronics. The authors disclose no conflicts of interest.
Figures
References
-
- Foster MF, Backous DD. Clinical evaluation of the patient with otosclerosis. Otolaryngol Clin North Am 2018; 51:319–326. - PubMed
-
- Nazarian R, McElveen JT, Jr, Eshraghi AA. History of otosclerosis and stapes surgery. Otolaryngol Clin North Am 2018; 51:275–290. - PubMed
-
- Merkus P, van Loon MC, Smit CF, et al. . Decision making in advanced otosclerosis: An evidence-based strategy. Laryngoscope 2011; 121:1935–1941. - PubMed
-
- Dumon T. Vibrant soundbridge middle ear implant in otosclerosis: Technique – indication. Adv Otorhinolaryngol 2007; 65:320–322. - PubMed
-
- Coordes A, Jahreiss L, Schönfeld U, et al. . Active middle ear implant coupled bilaterally to the round window despite bilateral implanted stapes prostheses. Laryngoscope 2017; 127:500–503. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
